Elara MD review

Almost nothing in this category will tell you what dose a price buys. Elara MD publishes eleven dose rungs across its two molecules with a figure against each, and the lowest semaglutide band is among the lowest published anywhere here — so someone deliberately staying small is billed accordingly rather than paying a full-dose plan's rate. The catch is that its two product pages each advertise an entry price that appears at no rung of that ladder, and billing runs every thirty days rather than per calendar month, so the annual cost is slightly above what the monthly figure implies. Read the ladder; the banners are not the price.

Vs median

$80/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Quotes off the lowest dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Elara MD dispenses through a 503A facility. No bloodwork is required before you start. A clinician review is included in the price.

Elara MD is a direct-to-consumer telehealth weight-loss and wellness brand selling compounded GLP-1 (semaglutide with B12) and compounded GLP-1/GIP with B12 (tirzepatide) as once-weekly self-injections, shipped as a 30-day supply every 30 days, alongside NAD+, sermorelin and glutathione. Care is fully online: a free intake visit is reviewed by a licensed provider within 24 hours, with a live video consult or secure chat required in some states. What sets it apart is the pricing page — its microdosing page publishes eleven dose rungs across the two molecules with a dollar figure against each, which almost nothing else in this category does. No pharmacy is named; the terms say a preferred pharmacy is used and the patient may direct the prescription elsewhere, and the GLP-1 + GIP page states the formulation is prepared in compliance with Section 503A.

The main GLP-1 page advertises "Starts at $199/month" and $199 appears at no rung of Elara's own published ladder — the cheapest semaglutide price it actually publishes is $249 at 0.2 mg/week. That page carries exactly one dollar figure and no milligram figure at all

• The identical mismatch repeats on the GLP-1 + GIP page, which claims "Starts at $249/month" while the cheapest published tirzepatide rung is $349 at 2.0 mg/week
• Billed every 30 days rather than per calendar month — 12.17 charges a year, so the effective annual cost runs about 1.4% above the advertised monthly figure
• No compounding pharmacy is named anywhere, and the terms explicitly disclaim endorsing any
• Does not publish which states it serves; the FAQ says only that it serves patients across multiple states
• No legal entity is named in the terms of use — the only corporate identifier on the site is the trade name
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Elara MD is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Microdosing tirzepatide
• Microdose & reconstitution calculator
• What a flat price costs at a low dose